Astellas Pharma Inc
SWB:YPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Astellas Pharma Inc
SWB:YPH
|
JP |
|
A
|
Abans Holdings Ltd
BSE:543712
|
IN |
|
GoldMoney Inc
F:O5U
|
CA |
|
Kanematsu Corp
F:S3K
|
JP |
|
S2Medical AB (publ)
F:S21
|
SE |
|
Endur ASA
F:4ZT0
|
NO |
|
Daphne International Holdings Ltd
OTC:DPNEF
|
CN |
|
PHC Holdings Corp
OTC:PHCCF
|
JP |
|
Hang Lung Properties Ltd
F:AOP
|
HK |
|
P
|
Pico Far East Holdings Ltd
XMUN:PJFB
|
HK |
|
Magnetite Mines Ltd
ASX:MGT
|
AU |
|
Fincantieri SpA
MIL:FCT
|
IT |
|
Mitani Corp
OTC:MITCF
|
JP |
|
H
|
Hellenic Telecommunications Organization SA
DUS:OTE
|
GR |
|
Intrakat Technical and Energy Projects SA
F:Z8M
|
GR |
|
P
|
Perseus Mining Ltd
DUS:P4Q
|
AU |
|
M
|
Mountain Province Diamonds Inc
F:MPG
|
CA |
|
Transcontinental Inc
F:53L
|
CA |
|
Salon Media Group Inc
OTC:SLNM
|
US |
|
C
|
Colibri Resource Corp
OTC:CRUCF
|
CA |
|
D
|
Douglas Emmett Inc
F:D8K
|
US |
|
C
|
Contrel Technology Co Ltd
TPEX:8064
|
TW |
|
E
|
Esker SA
F:EKE
|
FR |
|
P
|
PCCW Ltd
XMUN:TH3B
|
HK |
Wall St Price Targets
YPH Price Targets Summary
Astellas Pharma Inc
According to Wall Street analysts, the average 1-year price target for YPH is 12.86 EUR with a low forecast of 9.15 EUR and a high forecast of 17.35 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YPH's stock price target?
Price Target
12.86
EUR
According to Wall Street analysts, the average 1-year price target for YPH is 12.86 EUR with a low forecast of 9.15 EUR and a high forecast of 17.35 EUR.
What is the Revenue forecast for Astellas Pharma Inc?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is -5%.
What is the Gross Profit forecast for Astellas Pharma Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is -2%.
What is the Pre-Tax Income forecast for Astellas Pharma Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 2 years is 9%.
What is the Net Income forecast for Astellas Pharma Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 2 years is 5%.
